Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Discovery Life Sciences (DLS), a leading US-based provider of biospecimens and laboratory services, empowers groundbreaking biomedical research worldwide. Founded in 2018, DLS quickly established itself as "The Biospecimen and Biomarker Specialists," offering unparalleled access to high-quality human biological samples.
Specialising in medical laboratories and research services, DLS supports critical drug discovery and development across North America, Europe, and Asia. Their comprehensive portfolio includes human biological materials, genomic services, flow cytometry, and IHC/IF services, all delivered with scientific expertise and meticulous quality control.
DLS's unique value lies in its integrated scientific platforms and extensive biospecimen inventory, enabling researchers to accelerate discoveries from translational research through clinical trials. As a rapidly growing and innovative force, Discovery Life Sciences is redefining the standards for biospecimen procurement and scientific services in the life sciences sector.
28
DitchCarbon score
+2 vs industry average
Discovery Life Sciences’s score of 28 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Discovery Life Sciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Medical Laboratories is among the least carbon-intensive industries
Industry performance
0.186
20182025
The Medical Laboratories industry has reduced its overall emissions by 28% since 2018
Reported emissions
No reported emissions data is available for Discovery Life Sciences yet.
Discovery Life Sciences's reported carbon emissions
Discovery Life Sciences, a US-based medical laboratories firm, has set ambitious near-term Science Based Targets initiative (SBTi) climate commitments. The company aims to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42.36% by 2031, using a 2024 base year. Additionally, Discovery Life Sciences is committed to reducing absolute Scope 3 GHG emissions from fuel- and energy-related activities and employee commuting by 20.2% by 2031, also from a 2024 base year. These Scope 1 and 2 targets are classified as consistent with keeping global warming to 1.5°C. Furthermore, Discovery Life Sciences has committed that 69.2% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2031.
Assessing Discovery Life Sciences as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Discovery Life Sciences and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Discovery Life Sciences’s Climate Goals (2030 & 2050)
3 goals2031
42.36% reduction in Scope 2
Discovery Life Sciences commits to reduce absolute scope 1 and 2 GHG emissions 42.36% by 2031 from a 2024 base year.
Insufficient data42.36%
2031
42.36% reduction in Scope 1
Discovery Life Sciences commits to reduce absolute scope 1 and 2 GHG emissions 42.36% by 2031 from a 2024 base year.
Insufficient data42.36%
2031
20.2% reduction in scope 3 total
Discovery Life Sciences commits to reduce absolute scope 3 GHG emissions from fuel- and energy-related activities and employee commuting 20.…
Insufficient data20.2%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
2031 targetSee details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Discovery Life Sciences1 year ago
28
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more